Mark Brosius Sells 648 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

by · The Cerbat Gem

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) SVP Mark Brosius sold 648 shares of the business’s stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $495.20, for a total transaction of $320,889.60. Following the transaction, the senior vice president directly owned 2,906 shares in the company, valued at approximately $1,439,051.20. The trade was a 18.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Mark Brosius also recently made the following trade(s):

  • On Wednesday, March 4th, Mark Brosius sold 2,362 shares of Intuitive Surgical stock. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16.
  • On Tuesday, March 3rd, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $488.10, for a total transaction of $316,288.80.
  • On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36.
  • On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $4.48 during trading on Thursday, hitting $496.70. The company’s stock had a trading volume of 1,541,063 shares, compared to its average volume of 2,057,887. The company has a market capitalization of $176.39 billion, a PE ratio of 62.95, a PEG ratio of 3.83 and a beta of 1.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The stock’s 50-day moving average price is $525.02 and its two-hundred day moving average price is $512.10.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the business earned $2.21 EPS. Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently bought and sold shares of the stock. SteelPeak Wealth LLC grew its position in Intuitive Surgical by 28.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after buying an additional 9,364 shares in the last quarter. Atlantic Union Bankshares Corp raised its position in shares of Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after buying an additional 3,676 shares in the last quarter. World Investment Advisors lifted its stake in shares of Intuitive Surgical by 238.3% in the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after acquiring an additional 3,803 shares during the period. E. Ohman J or Asset Management AB boosted its holdings in shares of Intuitive Surgical by 4.1% in the third quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock valued at $12,659,000 after acquiring an additional 1,123 shares in the last quarter. Finally, Valley Wealth Managers Inc. boosted its holdings in shares of Intuitive Surgical by 52.7% in the third quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock valued at $1,826,000 after acquiring an additional 1,409 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on ISRG. UBS Group set a $570.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Tuesday, February 24th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 19th. Truist Financial lifted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Finally, BTIG Research reaffirmed a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Check Out Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Featured Stories